Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
The Value of Teledermatology Advice For Skin Toxicity in Oncology: Experience From a Pilot Study
Sofie Mylle;
Jorien Papeleu;
Isabelle Hoorens;
Evelien Verhaeghe;
Lieve Brochez
ABSTRACT
Despite skin toxicity during anti-EGFR therapy occurs frequently and significantly impacts patients’ quality of life, it is often not recognized nor optimally managed. This may lead to unnecessary dose reductions or treatment discontinuations of the cancer treatment. Access to rapid dermatology advice may be limited in hospitals. In this multicenter pilot study, we conclude that teledermatology may add value for both patients and oncologists in the management of treatment-induced skin toxicity.
Citation
Please cite as:
Mylle S, Papeleu J, Hoorens I, Verhaeghe E, Brochez L
The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study